Androgen receptor modulators and methods for their use
US11485713B2 · kind B2 · utility
7Cited by
34References
28Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 24, 2019 |
| Grant date | Nov 1, 2022 |
| Priority date | — |
| Expiry date | Jul 18, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D333/32
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds having a structure of formula (I), (I-A), (Ia)-(Ie), (A)-(E), and (II) or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof are provided. Uses of such compounds for modulating androgen receptor activity, imaging diagnostics in cancer and therapeutics, and methods for treatment of disorders including prostate cancer are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.